Dr. Sehgal is the Robotics/Minimally Invasive Surgery fellow in the Division of Urology.  After graduating from Weill Medical College of Cornell University and completing a one year fellowship at the Surgery Branch of the National Institutes of Health, he completed his urology residency at the University of Pennsylvania.  His primary interests are in general urology and minimally invasive urologic surgery.

Clinical Research Training Program Fellow, Surgery Branch, National Cancer Institute
National Institutes of Health
Bethesda, Maryland

• Phi Beta Kappa
• American Urological Association
• American College of Surgeons
• Society of Laparoendoscopic Surgeons
• American Association of Clinical Urologists
• Endourological Society

1. Cole GW, Alleva AM, Zuo JT, Sehgal SS, Yeow WS, Schrump DS, Nguyen DM. Suppression of Pro-metastasis Phenotypes Expression in Malignant Pleural Mesothelioma by the PI3K Inhibitor LY294002 or the MEK Inhibitor UO126. Anticancer Research. 2006 Mar- Apr;26(2A):809-21
2. Yeow WS, Baras A, Chua A, Nguyen DM, Sehgal SS, Schrump DS, Nguyen DM. Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2L/TRAIL (Tumor Necrosis Factor-Related Apoptosis Inducing Ligand). The Journal of Thoracic and Cardiovascular Surgery, 132(6): 1356-1362, 2006
3. Sehgal SS, Chu DI, Otto BJ, Acosta DN, Goldstein M. Survey of Varicocelectomy: Techniques employed by AUA Urologists. Podium Presentation. American Urological Association Annual Meeting. May 17-22, 2008. Orlando, FL.
4. Sehgal SS, Yeow WS, Hussain M, Loehfelm A, Blansfield J, Libutti SK, Thomas C, Nguyen DM. Targeting tumor angiogenesis in thoracic malignancies using MEK pharmacologic inhibitor: in vitro and in vivo analysis. Podium Presentation. 88th American Association for Thoracic Surgery Annual Meeting. May 10-14, 2008, San Diego, CA.
5. Sehgal SS, Nguyen DM, Yeow WS, Chua A, Zuo JT, Schrump DS, Nguyen DM. MEK/ERK 1/2 pathway inhibitor UO126 inhibits production of pro-angiogenesis cytokines and inhibits cell proliferation in thoracic cancer cells. Poster presentation, 97th American Association for Cancer Research Annual Meeting, April 1-5, 2006, Washington, DC.
6. Yeow WS, Chua A, Nguyen DM, Sehgal SS, Fang B, Schrump DS, Nguyen DM. Cytotoxic gene therapy of esophageal cancers using the recombinant RGD-modified adenovirus expressing membrane-bound TRAIL (TNF-Related Apoptosis-Inducing Ligand): an in vitro and in vivo analysis. Poster presentation, 97th American Association for Cancer Research Annual Meeting, April 1-5, 2006, Washington, DC.
7. Sehgal SS, Wein AJ, Bing Z, Malkowicz SB, Guzzo TJ. Neuroendocrine Tumor of the Bladder: A Case Report and Review of the literature. Reviews in Urology. In Press.
8. Steixner BL, Sehgal SS, Kojima Y, Lambert SM, Casale P. Multiple Metachranous Fibroepithelial Polyps in Children: An Emerging Phenotype? Podium Presentation. American Urological Association Annual Meeting. April 25-30, 2009. Chicago, IL.
9. Kasturi S, Sehgal SS, Christman MS, Lambert SM, Casale P.  Prospective Long-term Analysis of Nerve-sparing Extravesical Robotic-assisted Laparoscopic Ureteral Reimplantation. Urology 79(3):680-3, Mar 2012
10. Cadillo-Chavez, R, LLukani, E, Sehgal SS, Lee, D, Eun D.  Off-Clamp Vs. Clamp Robotic Partial Nephrectomy. World Congress of Endourology Annual Meeting, November 30-December 3rd, 2011, Kyoto, Japan.
11. Cadillo-Chavez R, Llukani E, Sehgal SS, Graves RV, Lee DI and Eun D. Comparison of Robotic Partial Nephrectomy Experience in Obese and Non-Obese Patients, World Congress of Endourology Annual Meeting, November 30-December 3rd, 2011, Kyoto, Japan.